Trial
NCT00895245
Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
University of Washington
Collaborators
National Cancer Institute (NCI)
Condition
Nausea and Vomiting
Intervention
fosaprepitant dimeglumine
Why stopped
Study stopped due to lack of efficacy in first 6 patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-18